However, it has been demonstrated that the HDAC inhibitor vorinostat (SAHA) promoted HIV-1 infection in CD4 + T cells, by enhancing the efficiency of post-entry events, including reverse transcription, nuclear import, and integration. The gene discussed is CD4; the disease is HIV-1 infection.